Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence

Summary

This pilot trial studies the side effects of ifetroban in treating patients with malignant solid tumors that are at high risk of coming back after treatment and spreading throughout the body. Platelets are a type of blood cells that help with clotting. Cancer cells stick to platelets and ride on them to get to different parts of the body. Drugs, such as ifetroban, may help these platelets become less "sticky," and reduce the chance of cancer cells spreading to other places in the body.

Timeline

Start

2018-12-12

Primary completion

2025-04

Completion

2026-04

Drugs

Indications